Live Breaking News & Updates on Deena Beasley Editing

Stay updated with breaking news from Deena beasley editing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Amgen quarterly revenue rises 6%, profit beats Street estimates

Amgen quarterly revenue rises 6%, profit beats Street estimates
reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.

United States , Peter Griffith , Thomson Reuters Trust Principles , Us Federal Trade Commission , Trade Commission , Horizon Therapeutics , Chief Financial Officer Peter Griffith , Wall Street , Deena Beasley Editing , Thomson Reuters Trust ,

Amgen quarterly revenue rises 6%, profit beats Street estimates

Amgen, which is facing U.S.
Federal Trade Commission delays to its planned acquisition
of Horizon Therapeutics, on Thursday reported higher
quarterly profit on strong sales of treatments for. ....

United States , Peter Griffith , Us Federal Trade Commission , Trade Commission , Horizon Therapeutics , Chief Financial Officer Peter Griffith , Wall Street , Deena Beasley Editing , Bill Berkrot ,

Eisai, Biogen Alzheimer's drug Leqembi would cost US Medicare up to $5 bln a year, study finds

Wide coverage of Alzheimer's drug Leqembi would raise future costs for the U.S. Medicare health plan by $2 billion to $5 billion a year, according to a study led by researchers at the University of California, Los Angeles (UCLA). ....

United States , Los Angeles , Eisai Co Ltd , Medicaid Services , Thomson Reuters Trust Principles , University Of California , Centers For Medicare , Drug Administration , Biogen Inc , Cave Arbanas , John Mafi , Deena Beasley Editing , Thomson Reuters Trust , Rsbi Regulatory Oversight , Rhpi Biopharma , Rhpi Drug Device Trials , Rhpi Regulatory , Ef Business Future Of Health ,

Amgen 1st quarter profit falls as costs rise, sales flatten

Amgen Inc on Thursday reported lower first-quarter profit as expenses rose and a 2% increase in sales of its own drugs was offset by lower revenue from its deal to manufacture COVID-19 antibody treatments for Eli Lilly and Co . ....

Puerto Rico , United States , Eli Lilly , Amgen Inc , Thomson Reuters Trust Principles , Horizon Therapeutics Plc , Deena Beasley Editing , Thomson Reuters Trust , Rhpi Commercial Strategy ,

Gilead details promising early COVID antiviral data, setting up larger studies

Gilead Sciences Inc on Tuesday unveiled data from the first human study of its experimental oral COVID-19 antiviral, saying the results in healthy volunteers cleared the way for two large Phase III trials of the drug that have begun enrolling patients. ....

Gilead Sciences Inc , World Health Organization , Thomson Reuters Trust Principles , Pfizer Inc Pfen Paxlovid , Merck Co Mrkn Lagevrio , European Congress , Sciences Inc , Anu Osinusi , World Health , Clinical Microbiology , Infectious Diseases , Deena Beasley Editing , Thomson Reuters Trust , Rsbi Regulatory Oversight , Rhpi Drug Device Trials , Rhpi Regulatory , Rhpi Public Health ,